Telix Pharmaceuticals | TLX - Vermögenswerte





Vermögenswerte Veränderung Datum
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesoblast USD 773.08M 9.23M 2026-06
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Pacific Edge NZD 17.6M 17.06M 2026-06
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.78B 280.91M 2026-03
Sonic Healthcare AUD 15.38B 550.57M 2024-12